LLY vs SOLV
By Alex · Tickerpine
Eli Lilly and Company vs Solventum Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | SOLV |
|---|---|---|
| Price | $1,233.66 | $91.61 |
| Market cap | $1.10T | $15.59B |
| P/E ratio | 41.8 | 11.2 |
| ROE | 102.29% | 33.96% |
| Profit margin | 33.53% | 17.26% |
| Revenue growth | 47.70% | 2.20% |
| Dividend yield | 0.55% | — |
| Beta | 0.51 | 0.67 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs SOLV in plain English
- LLY is the bigger company — about 70.5× the market cap of SOLV.
- SOLV is cheaper on earnings (P/E 11.2 vs 41.8).
- LLY earns a higher return on equity (102% vs 34%).
- LLY is growing revenue faster (48% vs 2%).
- LLY pays a dividend (0.55%) while the other effectively doesn't.
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
SOLV return calculator
See what $1,000 in Solventum Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.